Completed enrollment in Phase 2 LOTUS trial of AVTX-009 for the treatment of hidradenitis suppurativa; topline data expected mid-2026Appointed Kevin Lind to Board of DirectorsExpanded leadership team ...
A hidradenitis suppurativa expert doctor shares effective strategies for care, and where HS research is headed. ...